Coherus BioSciences, Inc.

CHRS

Sector
Healthcare

Industry
Biotechnology

Website
coherus.com




Buy / Sell (dollars)

1 Month

10.5% 10.5% Complete (success)
89.5% 89.5% Complete (danger)
$6,251.25
avg. $6,251.25
$53,106.81
avg. $53,106.81

Buy/Sell Ratio

0.118

Transactions

3

Filers

1

3 Month

0.7% 0.7% Complete (success)
99.3% 99.3% Complete (danger)
$18,753.75
avg. $6,251.25
$2.594M
avg. $864,638.66

Buy/Sell Ratio

0.007

Transactions

8

Filers

2

12 Month

3% 3% Complete (success)
97% 97% Complete (danger)
$840,396.90
avg. $70,033.08
$27.000M
avg. $2.250M

Buy/Sell Ratio

0.031

Transactions

62

Filers

12

24 Month

2.5% 2.5% Complete (success)
97.5% 97.5% Complete (danger)
$860,383.70
avg. $35,849.32
$33.123M
avg. $1.380M

Buy/Sell Ratio

0.026

Transactions

84

Filers

13

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers